1 min read|45 words
EchoNext, an FDA-cleared AI tool from Pathway Labs, now enables rapid detection of structural heart disease using standard ECG data. The technology integrates into OpenEvidence, expanding access to cardiac screening across healthcare systems. Faster diagnosis without additional imaging.
Read the full article on GMJ Newsroom →
Was this article helpful?
